Genvoya and Depression - a phase IV clinical study of FDA data
Summary:
Depression is reported as a side effect among people who take Genvoya (cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Truvada, and have Pain.
The phase IV clinical study analyzes which people have Depression when taking Genvoya. It is created by eHealthMe based on reports of 13,480 people who have side effects when taking Genvoya from the FDA, and is updated regularly.
What is Genvoya?
Genvoya has active ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 13,538 Genvoya users. Check the latest studies of Genvoya.
What is Depression?
Depression is found to be associated with 3,166 drugs and 4,125 conditions by eHealthMe. Check the latest studies of Depression.
13,480 people reported to have side effects when taking Genvoya.
Among them, 535 people (3.97%) have Depression.

Among these 535 people:
How long have people been on Genvoya when they have Depression? *
What is the gender of people who have Depression when taking Genvoya? *
What is the age of people who have Depression when taking Genvoya? *
What are other drugs people take besides Genvoya? *
What are other side effects people have besides Depression? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Genvoya and have Depression?
- Check whether Depression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Genvoya:
- Genvoya (13,538 reports)
Depression treatments and more:
- Depression (652,144 reports)
How severe was Depression and when was it recovered:
Expand to all the drugs that have ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate:
- Depression and drugs with ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate (549 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Genvoya:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Depression:
- Depression (3,166 drugs)
Browse all the conditions that are associated with Depression:
- Depression (4,125 conditions)
Related publications that referenced our studies
- Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
- Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate (the active ingredients of Genvoya) and Genvoya (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Zantac and Paraplatin - a second ago
- Could Entresto cause Yellow Skin? - a second ago
- Drug interactions of Enbrel and Sucralfate - 2 seconds ago
- Drug interactions of Methylprednisolone and Temaz - 3 seconds ago
- Could Enalapril Maleate And Hydrochlorothiazide cause Hyponatremia? - 14 seconds ago
- Drug interactions of Potassium Chloride and Magnesium Oxide - 44 seconds ago
- How effective is Ciprofloxacin Hydrochloride for Diverticulitis? - 47 seconds ago
- Could Januvia cause Body Temperature Decreased? - 52 seconds ago
- Could Emla cause Death? - 57 seconds ago
- Drug interactions of Breo Ellipta and Coenzyme Q10 - 58 seconds ago